This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
During the event, to take place at the Signia by Hilton Atlanta, innovators will gather in one room throughout the conference, gaining insights into regulatory approvals, clinical trials, market adoption, and the integration of novel technologies into patientcare.
The development has urged us to integrate the latest Artificial Intelligence with the healthcare system, including Cardiac Medicare. By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patientcare. AI recognizing cardiacarrests in emergency calls.
In this case, cardiology noted “old LBBB, negative Sgarbossa”, so they kept the patient in the ED for repeat ECGs and troponin levels. The patient still had chest pain and the ECG was repeated one hour later, labeled LBBB by the machine. The patient still had chest pain and a third ECG was performed. Learning points 1.
Fast and Efficient Care A portable ECG machine makes home monitoring of heart rates, rhythms, and cardiacarrest easier than before. The patient can perform an at-home ECG test with a damp towel to establish an electrical signal between the monitor and the body.
Image courtesy of Takenobu Shimada, Osaka Metropolitan University (CC BY 4.0, [link] mtaschetta-millane Mon, 07/29/2024 - 09:09 July 29, 2024 — When it comes to treating cardiacarrest, acting quickly can mean the difference between life and death. Cardiacarrest can lead to death within minutes.
Barr’s death at 39 from sudden cardiacarrest was caused by mitral valve prolapse—a heart valve defect that can affect the heart’s ability to pump blood. If a transcatheter approach turns out to be better for patients long term, that might give another option to patients who currently don’t have access to it.
Staying informed about these cutting-edge developments is critical for providing exceptional patientcare. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content